Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Authors: Perugino, Cory1 (AUTHOR), Culver, Emma L.2 (AUTHOR), Khosroshahi, Arezou3 (AUTHOR), Zhang, Wen4 (AUTHOR), Della-Torre, Emanuel5 (AUTHOR), Okazaki, Kazuichi6 (AUTHOR), Tanaka, Yoshiya7 (AUTHOR), Löhr, Matthias8 (AUTHOR), Schleinitz, Nicolas9 (AUTHOR), Falloon, Judith10 (AUTHOR), She, Dewei10 (AUTHOR), Cimbora, Daniel10 (AUTHOR), Stone, John H.1,11 (AUTHOR) jhstone@mgh.harvard.edu
Source: Rheumatology & Therapy. Dec2023, Vol. 10 Issue 6, p1795-1808. 14p.
Database: Academic Search Ultimate
Description
ISSN:21986576
DOI:10.1007/s40744-023-00593-7